Clinical impact of STK11 mutation in advanced-stage non-small cell lung cancer-Reference-Cited by-同舟云学术

Clinical impact of STK11 mutation in advanced-stage non-small cell lung cancer

Published:2022-09 Issue: Volume:172 Page:85-95
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Rosellini Pietro,Amintas Samuel,Caumont Charline,Veillon Rémi,Galland-Girodet Sigolène,Cuguillière Alain,Nguyen Laurent,Domblides Charlotte^ORCID,Gouverneur Amandine^ORCID,Merlio Jean-Philippe^ORCID,Bezin Julien^ORCID,Girodet Pierre-Olivier^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference48 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial;Herbst;Lancet,2016

3. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer;Borghaei;N Engl J Med,2015

4. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer;Brahmer;N Engl J Med,2015

5. Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial;Rittmeyer;Lancet,2017

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The histopathological spectrum and molecular changes associated with KRAS G12C mutation in non-small cell lung carcinoma;Pathology;2024-10

2. Loss of STK11 Suppresses Lipid Metabolism and Attenuates KRAS-Induced Immunogenicity in Patients with Non–Small Cell Lung Cancer;Cancer Research Communications;2024-08-01

3. A novel and potent MICA/B antibody is therapeutically effective inKRAS LKB1mutant lung cancer models;2024-07-31

4. Prognostic implications of STK11 with different mutation status and its relationship with tumor-infiltrating immune cells in non-small cell lung cancer;Frontiers in Immunology;2024-04-26

5. Effect of the STK11 mutation on therapeutic efficacy and prognosis in patients with non-small cell lung cancer: a comprehensive study based on meta-analyses and bioinformatics analyses;BMC Cancer;2024-04-17